James Condulis
Stock Analyst at Stifel
(2.94)
# 1,643
Out of 5,015 analysts
7
Total ratings
83.33%
Success rate
27.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Initiates: Buy | $24 | $16.26 | +47.60% | 1 | Sep 29, 2025 | |
| CYTK Cytokinetics | Maintains: Buy | $87 → $96 | $60.04 | +59.89% | 2 | Sep 2, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $44 | $37.05 | +18.76% | 1 | Jun 10, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $63.76 | +69.40% | 2 | Mar 28, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $15.11 | +98.54% | 1 | Jan 22, 2025 |
Aardvark Therapeutics
Sep 29, 2025
Initiates: Buy
Price Target: $24
Current: $16.26
Upside: +47.60%
Cytokinetics
Sep 2, 2025
Maintains: Buy
Price Target: $87 → $96
Current: $60.04
Upside: +59.89%
NewAmsterdam Pharma Company
Jun 10, 2025
Initiates: Buy
Price Target: $44
Current: $37.05
Upside: +18.76%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $63.76
Upside: +69.40%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $15.11
Upside: +98.54%